Characterization and assay of progesterone receptor in human mammary carcinoma.
[3H]Pregn-4-ene-3,20-dione ([3H]progesterone)-receptor complexes from human mammary carcinoma were found to be stabilized in the presence of glycerol. The dissociation rate constant was lowered and the equilibrium dissociation constant was decreased (KD=3 nM in the absence of glycerol and 1.1 nM in the presence of 30% glycerol), whereas no clear-cut effect on the association rate was observed and no change occurred in the concentration of binding sites. Cortisol was found to compete with [3H]progesterone only at concentrations higher than 1 muM. This made it possible to distinguish [3H]progesterone binding to the receptor from binding to corticosteroid-binding globulin. Synthetic progestins [6-chloro-17-acetoxypregna-4,6-diene-3,20-dione (chlromadinone acetate), 17alpha-ethinyl, 17-hydroxyestr-4-en-3-one (norethisterone), and 17,21-dimethyl-19-norpregna-4,9-diene-3,20-dione (R5020)] were found to have a high affinity for the receptor, whereas 5alpha-pregnane-3,20-dione had an affinity about one-half that of progesterone itself 5beta-Pregnane-3,20-dione, 17alpha-hydroxypregn-4-ene-3,20-dione (estradiol), 11beta,21-dihydroxy-pregn-4-ene-3,20-dione (corticosterone), estra-1,3,5(10)-triene-3,17beta-diol, and 17beta-hydroxyandrost-4-en-3-one (testosterone) were weak inhibitors of [3H]progesterone binding. Sedimentation on glycerol gradients showed different patterns in different tumors; i.e., [3H]progesterone specific binding having the characteristics of receptor was found either in the 8 S region, in the 4.5 S region, or in both. Activated progesterone-receptor complex from human mammary carcinoma cytosol was shown to bind to human DNA. An assay of the receptor based on these binding properties is described. This assay measures the total concentration of cytosol receptor since it makes possible the exchange of endogenous hormone for excess added [3H]progesterone. Of 55 biopsies examined by this method, 35 (64%) had a concentration of progesterone receptor-binding sites higher than 10 fmoles/mg protein. There was a positive correlation between the amounts of estrogen and progesterone receptors.
D004092:20-alpha-Dihydroprogesterone / Q000378:metabolism; D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000032:analysis*; D002499:Centrifugation, Density Gradient; D003345:Corticosterone / Q000378:metabolism; D003600:Cytosol / Q000378:metabolism; D004247:DNA / Q000378:metabolism; D004958:Estradiol / Q000378:metabolism; D004967:Estrogens / Q000378:metabolism; D005260:Female; D005990:Glycerol / Q000494:pharmacology; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism; D006908:Hydroxyprogesterones / Q000378:metabolism; D066298:In Vitro Techniques; D008875:Middle Aged; D011277:Pregnanediones / Q000378:metabolism; D011374:Progesterone / Q000378:metabolism; D045167:Progesterone Congeners / Q000378:metabolism; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone / Q000032:analysis* / Q000187:drug effects; D013739:Testosterone / Q000378:metabolism; D014156:Transcortin / Q000378:metabolism
D004967:Estrogens; D006908:Hydroxyprogesterones; D011277:Pregnanediones; D045167:Progesterone Congeners; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D004092:20-alpha-Dihydroprogesterone; D013739:Testosterone; D011374:Progesterone; D004958:Estradiol; D004247:DNA; D014156:Transcortin; D005990:Glycerol; D003345:Corticosterone; D006854:Hydrocortisone